halofenate has been researched along with Hyperlipemia in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ryan, JR | 1 |
| Ban, Y; Inoue, K; Kojima, T; Miyamoto, M; Nagashima, N | 1 |
| Witte, EC | 1 |
| Jain, AK; McMahon, FG; Ryan, JR | 1 |
| Azarnoff, DL; Dujovne, CA; Huffman, DH; Hurwitz, A; Pentikäinen, P; Shoeman, DW | 1 |
| Colman, RW | 2 |
| Joffe, BI; Krut, LH; Seftel, HC | 1 |
| Bassett, DR; Block, WD; Buckingham, RB; DiGaetano, R; Liou, LL; Mikkelsen, WM; Shakibai, A; Sidiq, M | 1 |
| Dorph, DJ; Smith, H; Yü, TF | 1 |
| Hamilton, RD; Hearn, T; Kanner, IF; Rees, ED; Wasson, S | 1 |
| Keller, C; Wolfram, G; Zöllner, N | 1 |
| Edwards, KD; Schapel, GJ | 1 |
| Rottiers, R; van Egmond, J | 1 |
| Eaton, RP; Oase, R; Schade, DS | 1 |
| Gotto, AM; Yeshurun, D | 1 |
| Aronow, WS; Harding, PR; Khemka, M; Khursheed, M; Nelson, WH; Pagano, J; Papageorge's, NP; Vangrow, JS | 2 |
| de Neuman, MP; Martiarena, JL; Neuman, J; Pesce, R; Talmasky, S; Valero, E | 1 |
| Fumagalli, R; Paoletti, R; Sirtori, C | 1 |
| Keller, C; Kilani, C; Wolfram, G; Zöllner, N | 1 |
| Bluhm, GB; Riddle, JM | 1 |
2 review(s) available for halofenate and Hyperlipemia
| Article | Year |
|---|---|
Hyperlipidemia in primary gout.
Topics: Adolescent; Adult; Aged; Aging; Alcohol Drinking; Cholesterol; Clofibrate; Dextrothyroxine; Diabetes Mellitus; Diet, Reducing; Gout; Halofenate; Humans; Hyperlipidemias; Male; Middle Aged; Obesity; Triglycerides | 1978 |
Hypolipidemic drugs.
Topics: Aminosalicylic Acids; Androgens; Bile Acids and Salts; Butyrates; Cellulose; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Female; Gonadal Steroid Hormones; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lignin; Lipid Metabolism; Lipid Mobilization; Male; Nafenopin; Neomycin; Nicotinic Acids; Oxandrolone; Probucol; Progestins; Sitosterols; Sterols; Thyroxine; Triglycerides | 1973 |
12 trial(s) available for halofenate and Hyperlipemia
| Article | Year |
|---|---|
The metabolic spectrum of halofenate.
Topics: Blood Glucose; Cholesterol; Clinical Trials as Topic; Clofibrate; Creatine Kinase; Glycolates; Halofenate; Humans; Hyperlipidemias; Probenecid; Protein Binding; Thyroid Function Tests; Thyroxine; Tolbutamide; Triglycerides; Uric Acid | 1975 |
Potentiation of hypoglycemic effect of sulfonylureas by halofenate.
Topics: Adult; Clinical Trials as Topic; Clofibrate; Diabetes Complications; Diabetes Mellitus; Drug Synergism; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Hypoglycemic Agents; Lipoproteins, VLDL; Male; Middle Aged; Phenformin; Sulfonylurea Compounds; Tolbutamide; Triglycerides | 1975 |
One-year trials with halofenate, clofibrate, and placebo.
Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholesterol; Clinical Trials as Topic; Clofibrate; Creatine Kinase; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Triglycerides; Uric Acid | 1976 |
Comparison of clofibrate with halofenate in diabetics with hyperlipidaemia.
Topics: Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Diabetes Complications; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides; Uric Acid | 1977 |
Effects of halofenate and probenecid on serum lipids and uric acid in hyperlipidemic, hyperuricemic adults.
Topics: Adult; Aged; Body Weight; Cholesterol; Clinical Trials as Topic; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Male; Middle Aged; Obesity; Probenecid; Triglycerides; Uric Acid | 1977 |
Halofenate in the treatment of type II hyperlipoproteinemia. Double blind comparison with clofibrate.
Topics: Adult; Blood Chemical Analysis; Body Weight; Cholesterol; Clinical Trials as Topic; Clofibrate; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides | 1976 |
[Treatment of hyperlipemia and hyperuricemia with 2-acetamidoethyl-(4-chlorophenyl)-(3-trifluoromethylphenoxy)-acetate (halofenate), a derivative of clofibrate].
Topics: Cholesterol; Clinical Trials as Topic; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Male; Probenecid; Triglycerides; Uric Acid | 1976 |
A one year double blind study of the effect of halofenate and clofibrate in patients with hyperlipoproteinemia.
Topics: Clofibrate; Drug Evaluation; Glycolates; Halofenate; Humans; Hyperlipidemias | 1975 |
Halofenate: an effective hypolipemia- and hypouricemia-inducing drug.
Topics: Adult; Clinical Trials as Topic; Coronary Disease; Depression, Chemical; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Time Factors; Triglycerides; Uric Acid | 1973 |
A double-blind comparison of the hypolipidemic and hypouricemic action of halofenate and clofibrate in patients with hyperlipoproteinemia (types III, IV and V).
Topics: Cholesterol; Chylomicrons; Clinical Trials as Topic; Clofibrate; Glycolates; Halofenate; Humans; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Triglycerides; Uric Acid | 1973 |
Halofenate, serum lipids, and exercise performance in coronary heart disease.
Topics: Adult; Aged; Angina Pectoris; Cholesterol; Clinical Trials as Topic; Coronary Disease; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Physical Exertion; Time Factors; Triglycerides | 1974 |
[First clinical experiences in therapy of hyperuricemia and hyperlipidemia with the clofibrate derivative MK 185].
Topics: Cholesterol; Clinical Trials as Topic; Glycolates; Gout; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Placebos; Triglycerides; Uric Acid | 1973 |
8 other study(ies) available for halofenate and Hyperlipemia
| Article | Year |
|---|---|
[Effects of halofenate on thyroxine-binding globulin (TBG) and thyroid function tests using TBG].
Topics: Adult; Aged; Alpha-Globulins; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Male; Middle Aged; Thyroid Function Tests; Thyroxine | 1976 |
Antihyperlipidaemic agents.
Topics: Animals; Cholesterol; Chylomicrons; Clofibrate; Dogs; Electrophoresis, Polyacrylamide Gel; Fatty Acids, Nonesterified; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Ion Exchange Resins; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids; Species Specificity; Structure-Activity Relationship; Triglycerides; Ultracentrifugation | 1975 |
Platelet function in thrombosis and atherosclerosis.
Topics: Adenylyl Cyclases; Arteriosclerosis; Blood Platelets; Cell Membrane; Clofibrate; Cyclic AMP; Halofenate; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Thrombosis | 1978 |
Platelet function in hyperbetalipoproteinemia.
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Blood Platelets; Clofibrate; Halofenate; Humans; Hyperlipidemias; Platelet Aggregation | 1978 |
Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia.
Topics: Animals; Body Weight; Butyrates; Cholesterol; Clofibrate; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Female; Glycolates; Halofenate; Hyperlipidemias; Lipids; Liver; Nephrotic Syndrome; Organ Size; Oxandrolone; Puromycin Aminonucleoside; Rats; Statistics as Topic | 1975 |
Altered insulin and glucagon secretion in treated genetic hyperlipemia: a mechanism of theraphy?
Topics: Animals; Arginine; Blood Glucose; Disease Models, Animal; Glucagon; Glycolates; Halofenate; Hyperglycemia; Hyperlipidemias; Insulin; Rats; Rats, Inbred Strains | 1976 |
Drug treatment of hyperlipidemia.
Topics: Aminosalicylic Acids; Anabolic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Estrogens; Halofenate; Humans; Hyperlipidemias; Neomycin; Nicotinic Acids; Progesterone; Sitosterols | 1976 |
Platelets and vascular disease in gout.
Topics: Allopurinol; Analgesics; Arteriosclerosis; Blood Platelets; Colchicine; Diabetes Complications; Gout; Halofenate; Humans; Hyperlipidemias; Hypertension; Hypoxanthines; In Vitro Techniques; Kidney Diseases; Uric Acid; Uricosuric Agents; Vascular Diseases; Xanthines | 1973 |